With the recent rumor surrounding the development of a possible vaccine against the new coronavirus, Russia successfully accelerated its recently launched Sputnik V vaccine. After that, it is more likely to release the vaccine for civilian use this week, according to a report.
The Sputnik V Covid vaccine, which is developed by the Gamaleya Research Institute of Epidemiology and Microbiology under the Russian Ministry of Health, may obtain permission to release a batch of its vaccine for civil use, said the institute’s deputy director of research. said an associate member of the Russian Federation. Academy of Sciences, Denis Logunov, according to a report.
“Your examination will begin in a few days. Also, in a few days we will obtain the permit. There is a certain procedure to authorize a batch for civil use. It must pass the quality control of the medical regulator Roszdravnadzor. In a few days, between the 10th of September and 13, we are going to obtain permission to release a batch of the vaccine for civilian use. Respectively, from that moment the population will begin to be vaccinated, “he said on the Rossiya-24 television news channel. reported the Russian news agency TASS.
The distribution of the vaccine will be in charge of the Ministry of Health.
Meanwhile, three Moscow outpatient clinics have received the first batch of a covid coronavirus vaccine for post-registration trials, the TASS news agency reported, citing Moscow Deputy Mayor Anastasia Rakova. Moscow residents can apply to participate in the study and be the first to get the vaccine, the deputy mayor said.
The study is part of post-registration clinical trials of the COVID-19 vaccine in which 40,000 people are expected to participate. Russia announced last month that its vaccine had already received approval, even though Russia’s Health Ministry said clinical trials were not yet complete.
Recently, the first tests of the Russian coronavirus vaccine showed encouraging results when details were released on Friday.
In the Lancet study, the Russian researchers reported on two small trials, each involving 38 healthy adults ages 18 to 60, who received a two-part immunization.
The report said the data showed the vaccine was “safe, well tolerated, and does not cause serious adverse events in healthy adult volunteers.”
Russia has said that industrial production of its version of the vaccine is expected starting this month.
Top Russian leaders, including Defense Minister Sergei Shoigu, have already been inoculated with the country’s covid vaccine, Sputnik News reported.
With contributions from agencies
.
